What is he best known for?
The fields of study he is best known for:
Gert Riethmüller mostly deals with Pathology, Antigen, Bone marrow, Monoclonal antibody and Molecular biology.
Gert Riethmüller has researched Pathology in several fields, including Cancer, Primary tumor and Complement system.
His work carried out in the field of Antigen brings together such families of science as Antibody and Virology.
His Bone marrow research integrates issues from Metastasis and Micrometastasis.
The concepts of his Monoclonal antibody study are interwoven with issues in Immunohistochemistry, Staining and Melanoma.
He interconnects Cell culture, Genetics, Nucleic acid sequence, Peptide sequence and Cytotoxic T cell in the investigation of issues within Molecular biology.
His most cited work include:
- Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. (846 citations)
- Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival (696 citations)
- Establishment of a human cell line (mono mac 6) with characteristics of mature monocytes (511 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Molecular biology, Monoclonal antibody, Antibody, Antigen and Immunology.
His Molecular biology research incorporates themes from Cell culture, Peripheral blood mononuclear cell, Monocyte, Epitope and Cytotoxic T cell.
His research integrates issues of Immunofluorescence and Glycoprotein in his study of Monoclonal antibody.
The various areas that Gert Riethmüller examines in his Antibody study include Spleen, In vitro and Immunotherapy.
His Antigen research incorporates elements of Receptor, Virology, Melanoma and Pathology.
His study explores the link between Pathology and topics such as Metastasis that cross with problems in Bone marrow.
He most often published in these fields:
- Molecular biology (36.14%)
- Monoclonal antibody (31.33%)
- Antibody (31.33%)
What were the highlights of his more recent work (between 1998-2019)?
- Cancer research (11.65%)
- Antibody (31.33%)
- Immunology (30.12%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Cancer research, Antibody, Immunology, Bone marrow and Pathology.
His Antibody study combines topics from a wide range of disciplines, such as Immune system, Immunotherapy and Antigen.
His Antigen research incorporates elements of Titer and Cytotoxic T cell.
His Immunology research is multidisciplinary, incorporating perspectives in Targeted therapy and In vivo.
His Pathology research incorporates themes from Survival analysis, Breast cancer and Metastasis.
His biological study spans a wide range of topics, including Epitope, Molecular biology, Antibody titer and Immunoglobulin G.
Between 1998 and 2019, his most popular works were:
- Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. (846 citations)
- Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival (696 citations)
- Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells (463 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Antibody
Gert Riethmüller mainly focuses on Immunology, Cancer research, T cell, Metastasis and Pathology.
His work deals with themes such as Antibody, MHC class I and Cytotoxicity, which intersect with T cell.
His Antibody study frequently draws parallels with other fields, such as Antigen.
His Antigen research is multidisciplinary, relying on both Targeted therapy and Chemotherapy.
His research in Metastasis intersects with topics in Neoplasm, Bone marrow and Genotype.
His Pathology study frequently draws connections to other fields, such as Genetic heterogeneity.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
